Rodriguez Barreto A, Walsh M, Robbins M, Mauguen A, Fiala E, Olcese C
Genet Med Open. 2024; 2:101836.
PMID: 39669595
PMC: 11613778.
DOI: 10.1016/j.gimo.2024.101836.
Davis M, Guarini E, OConnor K, Francis J, Abramson D
J Pediatr Ophthalmol Strabismus. 2024; 62(1):27-32.
PMID: 39254185
PMC: 11757066.
DOI: 10.3928/01913913-20240807-02.
Hicks R, Ji X, Zou Y, Sultana S, Rashid R, Sherief S
Invest Ophthalmol Vis Sci. 2024; 65(4):39.
PMID: 38662390
PMC: 11055500.
DOI: 10.1167/iovs.65.4.39.
Mohammad M, Mehyar M, Halalsheh H, Shehada R, Al Adawi O, Khzouz J
J Clin Med. 2024; 13(7).
PMID: 38610910
PMC: 11012679.
DOI: 10.3390/jcm13072146.
Lukamba R, Budiongo A, Monga B, Yao A, Bey P, Chenge G
Cancer Rep (Hoboken). 2023; :e1949.
PMID: 38146612
PMC: 10849925.
DOI: 10.1002/cnr2.1949.
Ten things you learned in your residency about retinoblastoma that have changed the 2023 Victor T. Curtin Lecture.
Abramson D
Ophthalmic Genet. 2023; 44(4):321-326.
PMID: 36995014
PMC: 10688026.
DOI: 10.1080/13816810.2023.2189948.
Rehabilitation of pediatric retinoblastoma patients with ocular prostheses and their subsequent modifications: A 15-year retrospective study.
Legg L, Ahmed Z, Solano A, Seier K, OHara B, Kapetanakos M
J Prosthodont. 2023; 33(1):12-17.
PMID: 36951218
PMC: 11396823.
DOI: 10.1111/jopr.13681.
Biochemical measures of ovarian function in female survivors of retinoblastoma treated with intra-arterial melphalan: an initial report.
Marathe P, Dunkel I, Francis J, Antal Z, Gobin Y, Abramson D
Ophthalmic Genet. 2023; 43(6):806-808.
PMID: 36695494
PMC: 10364467.
DOI: 10.1080/13816810.2022.2132516.
Spotlight on Targeted Chemotherapy in Retinoblastoma: Safety, Efficacy, and Patient Outcomes.
Naseripour M, Mirshahi R, Kasraei H, Sedaghat A, Azimi F
Onco Targets Ther. 2022; 15:1545-1561.
PMID: 36579184
PMC: 9792108.
DOI: 10.2147/OTT.S370878.
Survival trends for patients with retinoblastoma between 2000 and 2018: What has changed?.
Abdelazeem B, Abbas K, Shehata J, El-Shahat N, Eltaras M, Qaddoumi I
Cancer Med. 2022; 12(5):6318-6324.
PMID: 36479934
PMC: 10028055.
DOI: 10.1002/cam4.5406.
Doxorubicin-Loaded Extracellular Vesicles Enhance Tumor Cell Death in Retinoblastoma.
Farhat W, Yeung V, Kahale F, Parekh M, Cortinas J, Chen L
Bioengineering (Basel). 2022; 9(11).
PMID: 36354582
PMC: 9687263.
DOI: 10.3390/bioengineering9110671.
Ocular survival after intra-arterial chemotherapy for retinoblastoma improves with accrual of experience and programmatic evolution.
Marasligiller S, Williams B, Vadivelu S, Correa Z, Abruzzo T, Di Nicola M
Pediatr Blood Cancer. 2022; 70(2):e30071.
PMID: 36349521
PMC: 9790034.
DOI: 10.1002/pbc.30071.
The Optos 200Tx Scanning Laser Ophthalmoscope Application in Retinoblastoma Patients' Follow-Up.
Cui X, Ji X, Shao Y, Zhao P, Li X
Biomed Res Int. 2022; 2022:5422360.
PMID: 35993040
PMC: 9388307.
DOI: 10.1155/2022/5422360.
Liquid biopsies in pediatric oncology: opportunities and obstacles.
Sundby R, Pan A, Shern J
Curr Opin Pediatr. 2021; 34(1):39-47.
PMID: 34840249
PMC: 8727502.
DOI: 10.1097/MOP.0000000000001088.
Outcome of salvage intra-arterial chemotherapy for recurrent retinoblastoma.
Li J, Jing C, Hua X, Liang T, Li J, Zhao P
Eye (Lond). 2021; 36(11):2106-2110.
PMID: 34654891
PMC: 9581931.
DOI: 10.1038/s41433-021-01693-w.
Comparison of peribulbar block and subtenon infiltration in pediatric enucleation for retinoblastoma.
Kalaiyarasan R, Shende D, Parthiban M, Lomi N
Indian J Ophthalmol. 2021; 69(8):2106-2110.
PMID: 34304187
PMC: 8482898.
DOI: 10.4103/ijo.IJO_2829_20.
Clinical evaluation of RB1 genetic testing reveals novel mutations in Vietnamese patients with retinoblastoma.
Hoang C, Duong H, Nguyen N, Nguyen S, Nguyen C, Nguyen B
Mol Clin Oncol. 2021; 15(3):182.
PMID: 34277001
PMC: 8278403.
DOI: 10.3892/mco.2021.2344.
Feasibility of Proton Beam Therapy as a Rescue Therapy in Heavily Pre-Treated Retinoblastoma Eyes.
Biewald E, Kiefer T, Geismar D, Schluter S, Manthey A, Westekemper H
Cancers (Basel). 2021; 13(8).
PMID: 33924716
PMC: 8069965.
DOI: 10.3390/cancers13081862.
Molecular Changes in Retinoblastoma beyond : Findings from Next-Generation Sequencing.
Francis J, Richards A, Mandelker D, Berger M, Walsh M, Dunkel I
Cancers (Basel). 2021; 13(1).
PMID: 33466343
PMC: 7796332.
DOI: 10.3390/cancers13010149.
Low-grade glioma: A rare second tumor in retinoblastoma survivors.
Dalvi N, Kleinerman R, Epelman S, Abramson D, Dunkel I
Pediatr Blood Cancer. 2020; 68(2):e28770.
PMID: 33063942
PMC: 8376183.
DOI: 10.1002/pbc.28770.